FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jan de Jong

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Geographic Areas

Netherlands

Phenomena

Disease Outbreaks

Procedures

Concepts & Ideas

Anatomy

Feces

Physiology

Antigenic Variation

Co-author Network

Publications

TOP 3
Kim B Westgeest; Theo M Bestebroer; Miranda de Graaf; Jan C de Jong; Mathieu Fourment; Albert D M E Osterhaus; Guus F Rimmelzwaan; Colin A Russell; Derek J Smith; Gavin J D Smith; Monique I J Spronken; R H T Van Beek; Ron A M Fouchier
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.
Jan C de Jong; Eelko Hak; A D M E Ab Osterhaus
[Influenza vaccination in the elderly makes sense. Many confounding factors in observational research].
G F Rimmelzwaan; Jan C de Jong; G A Donker; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jan de Jong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Kim B Westgeest; Theo M Bestebroer; Miranda de Graaf; Jan C de Jong; Mathieu Fourment; Albert D M E Osterhaus; Guus F Rimmelzwaan; Colin A Russell; Derek J Smith; Gavin J D Smith; Monique I J Spronken; R H T Van Beek; Ron A M Fouchier
Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.
The Journal of general virology 2012;93(Pt 9):1996-2007.
2010: Jan C de Jong; Eelko Hak; A D M E Ab Osterhaus
[Influenza vaccination in the elderly makes sense. Many confounding factors in observational research].
Nederlands tijdschrift voor geneeskunde 2010;154():A1171.
2008: G F Rimmelzwaan; Jan C de Jong; G A Donker; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
Nederlands tijdschrift voor geneeskunde 2008;152(39):2138-44.
2008: Jan C de Jong
[The practice guideline 'Influenza and influenza vaccination' (first revision) from the Dutch College of General Practitioners; a response from the perspective of virology].
Nederlands tijdschrift voor geneeskunde 2008;152(39):2111-2.
2008: Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.
Vaccine 2008;26 Suppl 4():D31-4.
2008: Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
The global circulation of seasonal influenza A (H3N2) viruses.
Science (New York, N.Y.) 2008;320(5874):340-6.
2007: Jan C de Jong; G F Rimmelzwaan; G A Donker; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[The 2006/'07 influenza season in the Netherlands and the vaccine composition for the 2007/'08 season].
Nederlands tijdschrift voor geneeskunde 2007;151(39):2158-65.
2007: Jan C de Jong
[Influenza vaccination in health-care workers: an effective method to reduce the consequences of influenza in health care users].
Nederlands tijdschrift voor geneeskunde 2007;151(39):2143-6.
2007: Jan C de Jong
[New target populations for influenza vaccination; recommendations of the Health Council of the Netherlands].
Nederlands tijdschrift voor geneeskunde 2007;151(39):2140-2.
2007: Jan C de Jong; Derek J Smith; Alan S Lapedes; Isabella Donatelli; Laura Campitelli; Giuseppe Barigazzi; K Van Reeth; T C Jones; Guus F Rimmelzwaan; A D M E Osterhaus; Ron A M Fouchier
Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.
Journal of virology 2007;81(8):4315-22.
2006: Guus F Rimmelzwaan; Jan C de Jong; G A Donker; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Nederlands tijdschrift voor geneeskunde 2006;150(40):2209-14.
2006: Jan C de Jong; Hubert G M Niesters; G J J van Doornum
Circulation of incorrectly labeled adenovirus 50 and 51 prototype preparations.
Journal of clinical microbiology 2006;44(9):3468.
2005: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; Adam Meijer; Ron A M Fouchier; A D M E Osterhaus
[The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
Nederlands tijdschrift voor geneeskunde 2005;149(42):2355-61.
2005: Jan C de Jong; A D M E Osterhaus
[The threatening influenza pandemic: a national store of oseltamivir is necessary].
Nederlands tijdschrift voor geneeskunde 2005;149(29):1618.
2004: Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Terry C Jones; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Mutations, drift, and the influenza archipelago.
Discovery medicine 2004;4(24):371-7.
2004: Guus F Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; A D M E Osterhaus
[The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
Nederlands tijdschrift voor geneeskunde 2004;148(40):1984-8.
2004: Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Mapping the antigenic and genetic evolution of influenza virus.
Science (New York, N.Y.) 2004;305(5682):371-6.
2004: Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
A previously undescribed coronavirus associated with respiratory disease in humans.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(16):6212-6.
2004: Jan C de Jong; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
Nederlands tijdschrift voor geneeskunde 2004;148(2):73-9.
2003: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; Albert D M E Osterhaus
[The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season].
Nederlands tijdschrift voor geneeskunde 2003;147(40):1971-5.
2003: Jan C de Jong; Abraham M Palache; Walter Emil Philipp Beyer; Guus F Rimmelzwaan; A C M Boon; A D M E Osterhaus
Haemagglutination-inhibiting antibody to influenza virus.
Developments in biologicals 2003;115():63-73.
2002: Guus F Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; A D M E Osterhaus
[The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season].
Nederlands tijdschrift voor geneeskunde 2002;146(39):1846-50.
2002: A D M E Osterhaus; Jan C de Jong; Guus F Rimmelzwaan; Eric C J Claas
H5N1 influenza in Hong Kong: virus characterizations.
Vaccine 2002;20 Suppl 2():S82-3.
2002: Walter Emil Philipp Beyer; Abraham M Palache; Jan C de Jong; A D M E Osterhaus
Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Vaccine 2002;20(9-10):1340-53.
2001: Jan C de Jong; Guus F Rimmelzwaan; Aad I M Bartelds; berry wilbrink; Ron A M Fouchier; Albert D M E Osterhaus
[2000/01 influenza season and the vaccine composition for the season 2001/'02].
Nederlands tijdschrift voor geneeskunde 2001;145(40):1945-50.
2001: Jan C de Jong; Paul P Heinen; W L A Loeffen; AP van Nieuwstadt; E C Claas; Theo M Bestebroer; K Bijlsma; C Verweij; Albert D M E Osterhaus; Guus F Rimmelzwaan; Ron A M Fouchier; Tjeerd G Kimman
Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.
Vaccine 2001;19(31):4452-64.
2001: Guus F Rimmelzwaan; Jan C de Jong; Theo M Bestebroer; Anton M van Loon; E C Claas; Ron A M Fouchier; Albert D M E Osterhaus
Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands.
Virology 2001;282(2):301-6.
2000: GF Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; J Wendelien Dorigo-Zetsma; RA Fouchier; AD Osterhaus
[Influenza season 1999/2000 and vaccine composition for the season 2000/01].
Nederlands tijdschrift voor geneeskunde 2000;144(41):1968-71.
2000: Jan C de Jong; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus
Influenza virus: a master of metamorphosis.
The Journal of infection 2000;40(3):218-28.
2000: Jan C de Jong; Walter Emil Philipp Beyer; Abraham M Palache; Guus F Rimmelzwaan; Albert D M E Osterhaus
Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
Journal of medical virology 2000;61(1):94-9.
2000: Adam Meijer; C F Dagnelie; Jan C de Jong; A De Vries; Theo M Bestebroer; Anton M van Loon; Aad I M Bartelds; Jacobus M Ossewaarde
Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices.
European journal of epidemiology 2000;16(12):1099-106.
1999: Jan C de Jong; A G Wermenbol; M W Verweij-Uijterwaal; K W Slaterus; P Wertheim-Van Dillen; G J Van Doornum; S H Khoo; J C Hierholzer
Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively.
Journal of clinical microbiology 1999;37(12):3940-5.
1999: GF Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; J Wendelien Dorigo-Zetsma; RA Fouchier; AD Osterhaus
[Influenza season 1998/99; composition of vaccine for 1999/2000].
Nederlands tijdschrift voor geneeskunde 1999;143(40):2015-8.
1999: Jan C de Jong; GF Rimmelzwaan; RA Fouchier; AD Osterhaus
[Influenza pandemics: past and future].
Nederlands tijdschrift voor geneeskunde 1999;143(40):1988-91.
1999: Guus F Rimmelzwaan; Marianne Baars; R H T Van Beek; P de Lijster; Jan C de Jong; Eric C J Claas; Albert D M E Osterhaus
Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine.
Vaccine 1999;17(20-21):2512-6.
1999: Douglas M Fleming; M Zambon; Aad I M Bartelds; Jan C de Jong
The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.
European journal of epidemiology 1999;15(5):467-73.
1999: Guus F Rimmelzwaan; Eric C J Claas; Geert van Amerongen; Jan C de Jong; Albert D M E Osterhaus
ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.
Vaccine 1999;17(11-12):1355-8.
1999: Jan C de Jong; AP van Nieuwstadt; Tjeerd G Kimman; W L A Loeffen; Theo M Bestebroer; K Bijlsma; C Verweij; Albert D M E Osterhaus; E C Class
Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy.
Vaccine 1999;17(11-12):1321-8.
1999: A C Andeweg; Theo M Bestebroer; M Huybreghs; Tjeerd G Kimman; Jan C de Jong
Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay.
Journal of clinical microbiology 1999;37(3):524-30.
1998: EC Claas; Aad I M Bartelds; J Wendelien Dorigo-Zetsma; GF Rimmelzwaan; Jan C de Jong; AD Osterhaus
[The influenza season 1997/'98 and the vaccine composition for 1998/'99].
Nederlands tijdschrift voor geneeskunde 1998;142(44):2423-7.
1998: G J Van Doornum; Jan C de Jong
Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method.
Journal of clinical microbiology 1998;36(10):2865-8.
1998: Jan C de Jong; EC Claas; AD Osterhaus
[Influenza A (H5N1) in Hong Kong: Forerunner of a pandemic or just a scientifically interesting phenomenon and a useful exercise in pandemiology?].
Nederlands tijdschrift voor geneeskunde 1998;142(22):1252-6.
1998: Eric C J Claas; Jan C de Jong; R H T Van Beek; Guus F Rimmelzwaan; Albert D M E Osterhaus
Human influenza virus A/HongKong/156/97 (H5N1) infection.
Vaccine 1998;16(9-10):977-8.
1998: Jan C de Jong; Eric C J Claas; Albert D M E Osterhaus
[Influenza A(H5N1) in Hong Kong: forerunner of a pandemic or an only scientifically interesting phenomenon and a useful exercise in pandemiology?].
Tijdschrift voor diergeneeskunde 1998;123(9):278-82.
1998: Eric C J Claas; Albert D M E Osterhaus; R H T Van Beek; Jan C de Jong; Guus F Rimmelzwaan; Dennis A Senne; S Krauss; Kennedy F Shortridge; R G Webster
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet 1998;351(9101):472-7.
1997: GF Rimmelzwaan; Jan C de Jong; Aad I M Bartelds; EC Claas; J K van Wijngaarden; AD Osterhaus
[Influenza in the 1996/'97 season; vaccine composition for the 1997/'98 season].
Nederlands tijdschrift voor geneeskunde 1997;141(36):1743-7.
1996: Eric C J Claas; Jan C de Jong; Aad I M Bartelds; G F Rimmelzwaan; J K van Wijngaarden; A D Osterhaus
[Influenza in the 1995/'96 season; vaccine composition for the 1996/'97 season].
Nederlands tijdschrift voor geneeskunde 1996;140(41):2047-50.
1996: Jan C de Jong
[Adenoviruses as causative agents in gastroenteritis].
Nederlands tijdschrift voor geneeskunde 1996;140(10):536-41.
1996: A H Kidd; M Jonsson; D Garwicz; A E Kajon; A G Wermenbol; M W Verweij; Jan C de Jong
Rapid subgenus identification of human adenovirus isolates by a general PCR.
Journal of clinical microbiology 1996;34(3):622-7.
1995: Jan C de Jong; Eric C J Claas; A D Osterhaus
Influenza types and patient population.
Lancet 1995;346(8991-8992):1713-4.
1995: Eric C J Claas; Jan C de Jong; Aad I M Bartelds; G F Rimmelzwaan; J K van Wijngaarden; A D Osterhaus
[Influenza in the 1994/95 season; composition of vaccine for the 1995/96 season].
Nederlands tijdschrift voor geneeskunde 1995;139(42):2154-8.
1995: Saye H Khoo; AS Bailey; Jan C de Jong; BK Mandal
Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology.
The Journal of infectious diseases 1995;172(3):629-37.
1995: Eric C J Claas; Jan C de Jong; Aad I M Bartelds; K Bijlsma; PH Rothbarth; R de Groot; G F Rimmelzwaan; A D Osterhaus
Influenza types and patient population.
Lancet 1995;346(8968):180.
1994: S R Wood; I R Sharp; Jan C de Jong; M W Verweij-Uijterwaal
Development and preliminary evaluation of an enzyme immunosorbent assay for the detection of adenovirus type 8.
Journal of medical virology 1994;44(4):348-52.
1994: Eric C J Claas; Y Kawaoka; Jan C de Jong; N Masurel; Robert G Webster
Infection of children with avian-human reassortant influenza virus from pigs in Europe.
Virology 1994;204(1):453-7.
1994: Eric C J Claas; Jan C de Jong; Aad I M Bartelds; J K van Wijngaarden; N Masurel; A D Osterhaus
[Influenza in the 1993/'94 season; composition of the vaccine for the 1994/'95 season].
Nederlands tijdschrift voor geneeskunde 1994;138(39):1966-9.
1994: K P Schofield; D J Morris; AS Bailey; Jan C de Jong; G Corbitt
Gastroenteritis due to adenovirus type 41 in an adult with chronic lymphocytic leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(2):311-2.
1993: Jan C de Jong; K Bijlsma; A G Wermenbol; M W Verweij-Uijterwaal; Harrie van Der Avoort; D Wood; AS Bailey; A D Osterhaus
Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes.
Journal of clinical microbiology 1993;31(6):1562-9.
1992: Jan C de Jong; M Démazure; M C Legrand-Quillien; G Le Lay; J Colin; A G Wermenbol; M W Verweij-Uÿterwaal; Harrie van Der Avoort; Claude Chastel
New developments in the molecular epidemiology of adenovirus 8 keratoconjunctivitis.
Journal of medical virology 1992;38(2):102-7.
1991: J Schirm; W L Manson; F P Schröder; Adam M Tegzess; Harrie van Der Avoort; Jan C de Jong
[An adenovirus epidemic in patients with kidney transplantation].
Nederlands tijdschrift voor geneeskunde 1991;135(29):1310-4.
1989: D Wood; Jan C de Jong; K Bijlsma; Harrie van Der Avoort
Development and evaluation of monoclonal antibody-based immune electron microscopy for diagnosis of adenovirus types 40 and 41.
Journal of virological methods 1989;25(3):241-50.
1989: D Wood; K Bijlsma; Jan C de Jong; C Tonkin
Evaluation of a commercial monoclonal antibody-based enzyme immunoassay for detection of adenovirus types 40 and 41 in stool specimens.
Journal of clinical microbiology 1989;27(6):1155-8.
1989: Harrie van Der Avoort; A G Wermenbol; T P Zomerdijk; J A Kleijne; J A van Asten; P Jensma; A D Osterhaus; A H Kidd; Jan C de Jong
Characterization of fastidious adenovirus types 40 and 41 by DNA restriction enzyme analysis and by neutralizing monoclonal antibodies.
Virus research 1989;12(2):139-57.
1988: Jan C de Jong; M F Paccaud; F M de Ronde-Verloop; N H Huffels; C Verwei; T F Weijers; P J Bangma; E van Kregten; J A Kerckhaert; F Wicki
Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands.
Annales de l'Institut Pasteur. Virology 1988;139(4):429-37.
1988: Jan C de Jong; F M de Ronde-Verloop; T M Veenendaal-van Herk; T F Weijers; K Bijlsma; A D Osterhaus
Antigenic heterogeneity within influenza A (H3N2) virus strains.
Bulletin of the World Health Organization 1988;66(1):47-55.
1986: Jan C de Jong; J M de Ronde-Verloop; P J Bangma; E van Kregten; J Kerckhaert; M F Paccaud; F Wicki; W Wunderli
Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986.
Lancet 1986;2(8519):1329-30.
1986: Harrie van Der Avoort; T Adrian; R Wigand; A G Wermenbol; T P Zomerdijk; Jan C de Jong
Molecular epidemiology of adenovirus type 21 in the Netherlands and the Federal Republic of Germany from 1960 to 1985.
Journal of clinical microbiology 1986;24(6):1084-8.
1985: Jan C de Jong; A G Wermenbol; T P Zomerdijk; Harrie van Der Avoort
[Return of adenovirus 21 to the Netherlands].
Nederlands tijdschrift voor geneeskunde 1985;129(52):2521-2.
1985: Jan C de Jong; Harrie van Der Avoort; R Wigand; T Adrian
Revival of adenovirus 21 in Netherlands and West Germany.
Lancet 1985;2(8458):776.
1985: R W Ruigrok; P C Krijgsman; F M de Ronde-Verloop; Jan C de Jong
Natural heterogeneity of shape, infectivity and protein composition in an influenza A (H3N2) virus preparation.
Virus research 1985;3(1):69-76.
1985: T F Weijers; A D Osterhaus; Walter Emil Philipp Beyer; J A van Asten; F M de Ronde-Verloop; K Bijlsma; Jan C de Jong
Analysis of antigenic relationships among influenza virus strains using a taxonomic cluster procedure. Comparison of three kinds of antibody preparations.
Journal of virological methods 1985;10(3):241-50.
1984: A D Osterhaus; T F Weijers; K Bijlsma; F M de Ronde-Verloop; J A van Asten; Jan C de Jong
Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system.
Developments in biological standardization 1984;57():245-50.
1984: Jan C de Jong; R Wigand; T Adrian; J C Hierholzer; J G Kapsenberg; C J Muzerie; A G Wermenbol
Adenovirus 38: a new human adenovirus species of subgenus D.
Intervirology 1984;22(3):164-9.
1983: Jan C de Jong; R Wigand; A H Kidd; G Wadell; J G Kapsenberg; C J Muzerie; A G Wermenbol; R G Firtzlaff
Candidate adenoviruses 40 and 41: fastidious adenoviruses from human infant stool.
Journal of medical virology 1983;11(3):215-31.
1982: Jan C de Jong; F M de Ronde-Verloop; J W Dorpema
Testing of the strain identity of influenza vaccines by haemagglutination inhibition.
Journal of biological standardization 1982;10(3):175-83.
1981: Jan C de Jong; R Wigand; G Wadell; D Keller; C J Muzerie; A G Wermenbol; G J Schaap
Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D.
Journal of medical virology 1981;7(2):105-18.